Building Equity into the Equation: Stopping NAFLD & NASH in Black Americans
This article has been republished with permission from Cardiometabolic Health Congress partner Global Liver Institute. Read original article here. Nonalcoholic steatohepatitis (NASH) has a relatively short history as a recognized health condition. The terminology for NASH and its precursor nonalcoholic fatty liver disease (NAFLD) date back to only the 1980s. As a young disease, […]
International NASH Day: New Antibodies Discovered Play Significant Role in NAFLD
June 10th, 2021 celebrates International NASH Day which is part of an ongoing effort supported by CMHC partner, the Global Liver Institute to spread awareness of nonalcoholic steatohepatitis (NASH), the advanced form of nonalcoholic fatty liver disease (NAFLD), as well as actions to address the condition. Currently, the global burden of NAFLD is estimated at a worldwide […]
Ideal Cardiovascular Health Behaviors and NAFLD Prevalence
As a very common disorder, nonalcoholic fatty liver disease (NAFLD) is considered a significant risk factor for cardiovascular disease and a threat to cardiometabolic health. A series of ideal cardiovascular behaviors can be implemented as a prevention strategy to mitigate potential disease development. According to Ebenezer Oni, MD, MPH, cardiologist of the division of cardiology […]
Obesity Yields Spike in Nonalcoholic Fatty Liver Disease
At the recent annual meeting of the American College of Physicians, it was declared that nonalcoholic fatty liver disease (NAFLD) is the 21st century epidemic in liver disease—given the extraordinary growth in the disease’s prevalence, due to the related epidemics of both obesity and type 2 diabetes mellitus. Statistics indicate that the global prevalence of […]
